Status:
UNKNOWN
Retrospective Cohort Study of Intracerebral Hemorrhage
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
Intracerebral Hemorrhage
Eligibility:
All Genders
18-100 years
Brief Summary
The investigators design a retrospective, observational cohort study to provide contemporary information on the prevalence, characteristics, risk stratification，cost-effective, treatments and prognosi...
Detailed Description
Intracerebral hemorrhage (ICH) remains a devastating disease with high mortality, yet few therapeutic managements have been proved effective. Large quantities of work needs to be done to fully delinea...
Eligibility Criteria
Inclusion
- Hospitalized patients over 18 years old of primary intracerebral hemorrhage.
Exclusion
- patients of secondary intracerebral hemorrhage，such as hemorrhagic transformation of ischemic stroke, aneurysmal, cavernomas, arterio- venous malformations, central venous thrombosis, trauma-related, or tumor
- isolated intraventricular hemorrhage or subarachnoid hemorrhage pregnant patients
- unavailability to get complete blood cell samples and presenting contraindications or refusal to MRI
- patients cannot be followed up for any reasons.
- patients death in 24 hours
- pregnant patients
- surgical evacuation of hematoma
Key Trial Info
Start Date :
January 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT04803292
Start Date
January 1 2012
End Date
October 1 2025
Last Update
March 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
2nd Affiliated Hospital, School of Medicine at Zhejiang University
Hangzhou, Zhejiang, China, 310000